ALDO MANUEL NAVARRO OVIEDO

Allopathic & Osteopathic Physicians|Internal Medicine BRONX, NY NPI 1235487703

General Payments — all program years on this page

$1,129.57

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 54
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $874.87 across 41 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $874.8741

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $49.972
2021 $33.492
2023 $171.249
2024 $874.8741

Records — PY2024 (41)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086194538 Bayer Healthcare Pharmaceuticals Inc. $17.62 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097610203 Novo Nordisk Inc $24.86 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104218637 AstraZeneca Pharmaceuticals LP $19.24 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104388887 AstraZeneca Pharmaceuticals LP $15.86 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104594498 AstraZeneca Pharmaceuticals LP $20.80 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105104717 ABBVIE INC. $27.49 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105259092 AstraZeneca Pharmaceuticals LP $24.07 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105297818 AstraZeneca Pharmaceuticals LP $23.21 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105469393 AstraZeneca Pharmaceuticals LP $21.10 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105517873 AstraZeneca Pharmaceuticals LP $5.04 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105538257 AstraZeneca Pharmaceuticals LP $21.54 07/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114521480 Exact Sciences Corporation $24.89 05/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114521484 Exact Sciences Corporation $25.30 07/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117337235 Amgen Inc. $17.82 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117337237 Amgen Inc. $26.85 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117337239 Amgen Inc. $31.91 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117337241 Amgen Inc. $33.68 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117337243 Amgen Inc. $15.31 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131450989 PFIZER INC. $24.98 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753784 Gilead Sciences, Inc. $29.40 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753786 Gilead Sciences, Inc. $6.81 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753788 Gilead Sciences, Inc. $24.77 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753790 Gilead Sciences, Inc. $19.29 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753792 Gilead Sciences, Inc. $34.21 05/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753794 Gilead Sciences, Inc. $8.92 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753796 Gilead Sciences, Inc. $8.07 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133753798 Gilead Sciences, Inc. $17.43 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135996098 Lilly USA, LLC $22.69 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136016727 Lilly USA, LLC $30.00 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136016997 Lilly USA, LLC $21.48 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136018045 Lilly USA, LLC $27.28 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139363073 Astellas Pharma US Inc $20.80 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139369739 Astellas Pharma US Inc $22.82 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139388726 Astellas Pharma US Inc $25.52 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139409423 Astellas Pharma US Inc $23.43 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139428290 Astellas Pharma US Inc $26.98 10/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151742136 Teva Pharmaceuticals USA, Inc. $13.10 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151742172 Teva Pharmaceuticals USA, Inc. $13.80 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151742174 Teva Pharmaceuticals USA, Inc. $19.83 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151742190 Teva Pharmaceuticals USA, Inc. $22.58 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151742192 Teva Pharmaceuticals USA, Inc. $14.09 12/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.